Cytokines and Extracellular Matrix Remodeling in the Central Nervous System

NeuroImmune Biology

Volumn 6, Issue C, 2008, Pages 167-197

  Wiranowska, Marzenna ^a   Plaas, Anna ^b  

^a Departments of Pathology and Cell Biology and Internal Medicine

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957046739     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)10009-0     Document Type: Review

References (156)

1. Sykova E. Plasticity of extracellular space. In: Walz W. (Ed). In The Neuronal Environment (2002), Humana Press Inc. 57-81
2. Garwood J., Heck N., Rigato F., and Faissner A. The extracellular matrix in neural development, plasticity, and regeneration. In: Walz W. (Ed). In The Neuronal Environment (2002), Humana Press Inc. 109-158
3. Schonherr E., and Hausser HJ. Extracellular matrix and cytokines: a functional unit. Dev Immunol 7 (2000) 89-101
4. Schwartz M.A., and Ginsberg MH. Networks and altered crosstalk: integrin signalling spreads. Nat Cell Biol E (2002) 65-68
5. Schuppan D., and Ruhl M. Matrix in signal transduction and growth factor modulation. Braz J Med Biol Res 27 (1994) 2125-2141
6. BlumckeI, Eggli P, Celio MR. Relationship between astrocytic processes and "perineuronal nets" in rat neocortex. Glia 15:131-40.
7. Brightman M.W., and Kaya M. Permeable endothelium and the interstitial space of brain. Cell Mol Neurobiol 20 (2000) 111-130
8. Brightman MW. The brain's interstitial clefts and their glial walls. J Neurocytol 31 (2002) 596-603
9. Mercier F., Kitasako J.T., and Hatton GL. Fractones and their basal laminae in the hypothalamus. J Comp Neurol 455 (2003) 324-340
10. Doetsch F. A niche for adult neural stem cells. Curr Opin Genet Dev 13 (2003) 43-50
11. Shen Q., Goderie S.K., Jin L., Karanth N., Sun Y., Abramova N., Vincent P., Pumiglia K., and Temple S. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304 (2004) 1338-1340
12. Kearns S.M., Laywell E.D., Kukekov V.K., and Steindler DA. Extracellular matrix effects on neurosphere cell motility. Exp Neurol 182 (2003) 240-244
13. Reynolds B., and Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255 (1992) 1707-1710
14. Doetsch F., Garcia-Verdugo J.M., and Alvarez-Buylla A. Cellular composition and three-dimentional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 17 (1997) 5046-5061
15. Campos L.S., Decker L., Taylor V., and Skarnes W. Notch, epidermal growth factor receptor, and beta 1-integrin pathways are coordinated in neural cells. J Biol Chem 281 (2006) 5300-5309
16. Stumm R.K., Zhou C., Ara T., Lazarini F., Dubois-Dalcq M., Nagasawa T., Hollt V., and Schulz S. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 23 (2003) 5123-5130
17. Krathwohl M.D., and Kaiser JL. Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22 (2004) 109-118
18. Sim F.J., Lang J.K., Waldau B., Roy N.S., Schwartz T.E., Pilcher W.H., Chandross K.J., Natesan S., Merrill J.E., and Goldman SA. Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann Neurol 59 (2006) 763-779
19. Novak U., and Kaye AH. Extracellular matrix and the brain: components and function. J Clin Neurosci 7 (2000) 280-290
20. Steindler DA. Glial boundaries in the developing nervous system. Ann Rev Neurosci 16 (1993) 445-470
21. Garcion E., Halilagic A., Faissner A., and French-Constant C. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 131 (2004) 3423-3432
22. Garwood J., Garcion E., Dobbertin A., Heck N., Calco V., ffrench-Constant C., and Faissner A. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur J Neurosci 20 (2004) 2524-2540
23. Scadden DT. The stem cell niche as an entity of action. Nature 441 (2006) 1075-1079
24. Saghatelyan A., de Chevigny A., Schachner M., and Lledo PM. Tenascin-R mediates activity-dependent recruitment of neuroblasts in the adult mouse forebrain. Nat Neurosci 7 (2004) 347-356
25. Chekenya M., and Pilkington GJ. NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumors. J Neurocytol 31 (2002) 507-521
26. Heese O., Disko A., Zirkel D., Westphal M., and Lamszus K. Neural stem cell migration toward gliomas. Neuro-oncol 7 (2005) 476-484
27. Ben-Hur T., Ben-Yosef Y., Mizrachi-Kol R., Ben-Menachem O., and Miller A. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells. J Neuroimmunol 175 (2006) 12-18
28. Craig C.G., Tropepe V., Morshead C.M., Reynolds B.A., Weiss S., and Van der Kooy D. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci 16 (1996) 2649-2658
29. Whittemore S.R., Morassutti D.J., Walters W.M., Liu R.H., and Magnuson DS. Mitogen and substrate differentially affect the lineage restriction of adult rat subventricular zone neural precursor cell populations. Exp Cell Res 252 (1999) 75-95
30. Pedersen M.W., Tkach V., Pedersen N., Berezin V., and Poulsen HS. Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility. Int J Cancer 108 (2004) 643-653
31. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 (2003) 3983-3988
32. Drewes LR. What is the blood-brain barrier? A molecular perspective.Cerebral vascular biology. Adv Exp Med Biol 474 (1999) 111-122
33. Vlodavsky I., Folkman J., Sullivan R., Fridman R., Ishai-Michaeli R., Sasse J., and Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84 (1987) 2292-2296
34. Schilling L., and Wahl M. Mediators of cerebral edema. Adv Exp Med Biol 474 (1999) 123-141
35. Hirano A., Kawanami T., and Liena JF. Electron microscopy of the blood-brain barrierdisease. Microsc Res Tech 27 (1994) 543-556
36. Sixt M., Engelhardt B., Pausch F., Hallmann R., Wendler O., and Sorokin LM. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol 153 (2001) 933-946
37. Taipale J., and Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 11 (1997) 51-59
38. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., and Vlodavsky I. A heparin-binding angiogenic protein-basic fibroblast growth factor- is stored within basement membrane. Am J Pathol 130 (1988) 393-400
39. Loo B.M., and Salmivirta M. Heparin/heparan sulfate domains in binding and signaling of fibroblast growth factor 8b. J Biol Chem 277 (2002) 32616-32623
40. Spillmann D., Witt D., and Lindahl U. Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem 273 (1998) 15487-15493
41. Lortat-Jacob H., Turnbull J.E., and Grimaud JA. Molecular organization of the interferon gamma-binding domain in heparan sulfate. Biochem J 310 (1995) 497-505
42. Frevert C.W., Kinsella M.G., Vathanaprida C., Goodman R.B., Baskin D.G., Proudfoot A., Wells T.N.C., Wight T.N., and Martin TR. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am J Res Cell Mol Biol 28 (2003) 464-472
43. Marshall L.J., Ramdin L.S.P., Brooks T., Dphil P.C., and Shute JK. Plasminogen activator inhibitor-1 supports IL-8 mediated neutrophil transendothelial migration by inhibition of the consecutive shedding of endothelial IL8/heparan sulfate/syndecan-1 complexes. J Immunol 171 (2003) 2057-2065
44. Salek-Ardakani S., Arrand J.R., Shaw D., and Mackett M. Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 96 (2000) 1879-1888
45. Wolff E.A., Greenfield B., Taub D.D., Murphy W.J., Bennett K.L., and Aruffo A. Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44. Demonstration of the interaction between RANTES and chondroitin sulfate. J Biol Chem 274 (1999) 2518-2524
46. Bourdon M.A., and Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 108 (1989) 1149-1155
47. Norenberg U., Hubert M., and Rathjen FG. Structural and functional characterization of tenascin-R (restrictin), an extracellular matrix glycoprotein of glial cells and neurons. Int J Dev Neurosci 14 (1996) 217-231
48. Pesheva P., Gloor S., and Probstmeier R. Tenascin-R as a regulator of CNS glial cell function. Prog Brain Res 132 (2001) 103-114
49. Joester A., and Faissner A. The structure and function of tenascins in the nervous system. Matrix Biol 20 (2001) 13-22
50. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life 57 (2000) 276-289
51. Murakami T., and Ohtsuka A. Perisynaptic barrier of proteoglycans in the mature brain and spinal cord. Arch Histol Cytol 66 (2003) 195-207
52. Bruckner G., Grosche J H.-, Rubsamen M., Schmidt S., and Schachner M. Region and lamina-specific distribution of extracellular matrix proteoglycans, hyaluronan and tenascin-R in the mouse hippocampal formation. J Chem Neuroanat 26 (2003) 37-50
53. Steindler D.A., Settles D., Erickson H.P., Laywell E.D., Yoshiki A., Faissner A., and Kusakabe M. Tenascin knockout mice: barrels, boundary molecules, and glial scars. J Neurosci 15 (1995) 1971-1983
54. Bruckner G., Grosche J., Schmidt S., Hartig W., Margolis R.U., Delpech B., Seidenbecher C.I., Czaniera R., and Schachner M. Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R. J Comp Neurol 428 (2000) 616-629
55. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., Cohn RD R.-B.S., Westra S., Williamson R.A., Hoshi T., and Campbell KP. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418 (2002) 422-425
56. Freitag S., Schachner M., and Morellini F. Behavioral alterations in mice deficient for the extracellular matrix glycoprotein tenascin-R. Behav Brain Res 145 17 (2003) 189-207
57. Montag-Sallaz M., and Montag D. Severe cognitive and motor coordination deficits in tenascin-R-deficient mice. Genes Brain Behav 2 (2003) 20-31
58. Putthoff P., Akyuz N., Kutsche M., Zardi L., Borgmeyer U., and Schachner M. Structure of the murine tenascin-R gene and functional characterisation of the promoter. Biochem Biophys Res Commun 308 (2003) 940-949
59. Powell S.K., and Kleinman HK. Neuronal laminins and their cellular receptors. Int J Biochem Cell Biol 29 (1997) 401-414
60. Emsley J.G., and Hagg T. alpha6beta1 integrin directs migration of neuronal precursors in adult mouse forebrain. Exp Neurol 183 (2003) 273-285
61. Tsai H.H., and Miller RH. Glial cell migration directed by axon guidance cues. Trends Neurosci 25 (2002) 173-175
62. Barallobre MJ D., Rio J.A., Alcantara S., Borrell V., Aguado F., Ruiz M., Carmona M.A., Martin M., Fabre M., Yuste R T.-, Lavigne M., and Soriano E. Aberrant development of hippocampal circuits and altered neural activity in netrin 1-deficient mice. Development. 127 (2000) 4797-4810
63. Yebra M., Montgomery A.M., Diaferia G.R., Kaido T., Silletti S., Perez B., Just M.L., Hildbrand S., Hurford R., Florkiewicz E T.-, Lavigne M., and Cirulli V. Recognition of the neural chemoattractant netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration. Dev Cell 5 (2003) 695-707
64. Teyssier J.R., Rousset F., Garcia E., Cornillet P., and Laubriet A. Upregulation of the netrin receptor (DCC) gene during activation of B lymphocytes and modulation by interleukins. Biochem Biophys Res Commun 283 (2001) 1031-1036
65. Yamaguchi Y. Brevican: a major proteoglycan in adult brain. Perspect Dev Neurobiol 3 (1996) 307-317
66. Bovolenta P., and Fernaud-Espinosa I. Nervous system proteoglycans as modulators of neurite outgrowth. Prog Neurobiol 61 (2000) 113-132
67. Bandtlow C.E., and Zimmermann DR. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 80 (2000) 1267-1290
68. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 57 (2000) 276-289
69. Nishiyama A. NG2 cells in the brain: a novel glial cell population. Hum Cell 14 1 (2001) 77-82
70. Seidenbecher C.I., Smalla K.H., Fischer N., Gundelfinger E.D., and Kreutz MR. Brevican isoforms associate with neural membranes. J Neurochem 83 (2002) 738-746
71. Viapiano M.S., Matthews R.T., and Hockfield S. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. J Biol Chem 278 (2003) 33239-33247
72. Luckenbill-Edds L. Laminin and the mechanism of neuronal outgrowth. Brain Res Rev 23 (1997) 1-27
73. Leprini A., Gherzi R., Vecchi E., Borsi L., Zardi L., and Siri A. Rat tenascin-R gene: structure, chromosome location and transcriptional activity of promoter and exon 1. Cytogenet Cell Genet 83 (1998) 115-123
74. Koppe G., Bruckner G., Hartig W., Delpech B., and Bigl V. Characterization of proteoglycan-containing perineuronal nets by enzymatic treatments of rat brain sections. Histochem J 29 (1997) 11-20
75. Li H., Leung T.C., Hoffman S., Balsamo J., and Lilien J. Coordinate regulation of cadherin and integrin function by the chondroitin sulfate proteoglycan neurocan. J Cell Biol 149 (2000) 1275-1288
76. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., and Fawcett JW. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 20 1 (2000) 2427-2438
77. Grumet M., Friedlander D.R., and Sakurai T. Functions of brain chondroitin sulfate proteoglycans during developments: interactions with adhesion molecules. Perspect Dev Neurobiol 3 (1996) 319-330
78. Schmalfeldt M., Bandtlow CE D.-, Zimmermann M.T., Winterhalter K.H., and Zimmermann DR. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 113 (2000) 807-816
79. Paulus W., Baur I D.-, Zimmermann M.T., and Zimmermann DR. Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol 55 (1996) 528-533
80. Weber P., Bartsch U., Rasband M.N., Czaniera R., Lang Y., Bluethmann H., Margolis R.U., Levinson S.R., Shrager P., Montag D., and Schachner M. Mice deficient for tenascin-R display alterations of the extracellular matrix and decreased axonal conduction velocities in the CNS. J Neurosci 1 19 (1999) 4245-4262
81. Rezajooi K., Pavlides M., Winterbottom J., Stallcup W.B., Hamlyn P.J., Lieberman A.R., and Anderson PN. NG2 proteoglycan expression in the peripheral nervous system: upregulation following injury and comparison with CNS lesions. Mol Cell Nurosci 25 (2004) 572-584
82. Watanabe A., Mabuchi T., Satoh E., Furuya K., Zhang L., Maeda S., and Naganuma H. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression. J Neuro-oncol 77 (2006) 25-32
83. Reizes O., Lincecum J., Wang Z., Goldberg O., Huang L., Kaksonen M., Ahima R., Hinkes M.T., Barsh G.S., Rauvala H., and Bernfield M. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 106 (2001) 105-116
84. Hsueh Y.P., and Sheng M. Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development. J Neurosci 19 (1999) 7415-7425
85. Hoover C.L., Hilgenberg L.G., and Smith MA. The COOH-terminal domain of agrin signals via a synaptic receptor in central nervous system neurons. J Cell Biol 161 (2003) 923-932
86. Margolis R.K., Rauch U., Maurel P., and Margolis RU. Neurocan and phosphacan: two major nervous tissue-specific chondroitin sulfate proteoglycans. Perspect Dev Neurobiol 3 (1996) 273-290
87. Tang X., Davies J.E., and Davies SJ. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 71 (2003) 427-444
88. Senn C., Kutsche M., Saghatelyan A., Bosl M.R., Lohler J., Bartsch U., Morellini F., and Schachner M. Mice deficient for the HNK-1 sulfotransferase show alterations in synaptic efficacy and spatial learning and memory. Mol Cell Neurosci 20 (2002) 712-729
89. Kiernan B.W., Garcion E., Ferguson J., Frost E.E., Torres E.M., Dunnett S.B., Saga Y., Aizawa S., Faissner A., Kaur R., Franklin R.J., and Ffench-Constant C. Myelination and behaviour of tenascin-C null transgenic mice. Eur J Neurosci 11 (1999) 3082-3092
90. Garcion E., Faissner A., and Ffrench-Constant C. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128 (2001) 2485-2496
91. Brakebusch C., Seidenbecher C.I., Asztely F., Rauch U., Matthies H., Meyer H., Krug M., Bockers T.M., Zhou X., Kreutz M.R., Montag D., Gundelfinger E.D., and Fassler R. Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol Cell Biol (2002) 7417-7427
92. Lu M., Grove E.A., and Miller RJ. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 99 (2002) 7090-7095
93. Nakagami Y., Abe K., Nishiyama N., and Matsuki N. Laminin degradation by plasmin regulates long-term potentiation. J Neurosci 20 (2000) 2003-2010
94. Bukalo O., Schachner M., and Dityatev A. Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 104 (2001) 359-369
95. Hamel M.G., Mayer J., and Gottschall PE. Altered production and proteolytic processing of brevican by transforming growth factor beta in cultured astrocytes. J Neurochem 93 (2005) 1533-1541
96. Lauri S.E., Kaukinen S., Kinnunen T., Ylinen A., Imai S., Kaila K., Taira T., and Rauvala H. Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci 19 (1999) 1226-1235
97. Kaksonen M., Pavlov I., Voikar V., Lauri S.E., Hienola A., Riekki R., Lakso M., Taira T., and Rauvala H. Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory. Mol Cell Neurosci 21 (2002) 158-172
98. Raulo E., Tumova S., Pavlov I., Pekkanen M., Hienola A., Klankki E., Kalkkinen N., Taira T., Kilpelainen I., and Rauvala H. The two thrombospondin type I repeat domains of the heparin-binding growth-associated molecule bind to heparin/heparan sulfate and regulate neurite extension and plasticity in hippocampal neurons. J Biol Chem 280 (2005) 41576-41583
99. Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11 (2006) 1696-1701
100. Lepperd D., Lindberg R.L., Kappos L., and Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammationmultiple sclerosis bacterial meningitis. Brain Res Brain Res Rev 36 (2001) 249-257
101. Held-Feindt J., Paredes E.B., Blomer U., Seidenbecher C., Stark A.M., Mehdorm H.M., and Mentlein R. Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer 118 (2006) 55-61
102. Vitkovic L., Bockaert J., and Jacque C. "Inflammatory" cytokines:neuromodulators in normal brain?. J Neurochem 74 (2000) 457-471
103. Schneider H., Pitossie F., Balschun D., Wagner A D., Rey A., and Besedowsky HO. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 95 (1998) 7778-7783
104. Schwab J.M., Beschorner R., Nguyen T.D., Meyermann R., and Schluesener HJ. Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J Neurotrama 18 (2001) 377-388
105. Lagord C., Berry M., and Logan A. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci 20 (2002) 69-92
106. Smith G.M., and Strunz C. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52 (2005) 209-218
107. Garcia de Yebnes E., Ho A., Damani T., Fillit H., and Blum M. Regulation of the heparin sulfate proteoglycan, perlecan, by injury and interleukin-1alpha. J Neurochem 73 (1999) 812-820
108. DiProspero N.A., Meiners S., and Geller HM. Inflammatory cytokines interact to modulate extracellular matrix and astrocytic support of neurite outgrowth. Exp Neurol 148 (1997) 628-639
109. Moran L.B., Duke D.C., Turkheimer F.E., Banati R.B., and Graeber MB. Towards a transcriptome definition of microglial cells. Neurogenetics 5 (2004) 95-108
110. Milner R., and Campbell IL. Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin. J Neurosci 22 (2002) 1562-1572
111. Milner R., and Campbell IL. The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol 170 (2003) 3850-3858
112. Gilat D., Cahalon L., Hershkoviz R., and Lider O. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol Today 17 (1996) 16-20
113. Ohuchida K., Mizumoto K., Murakami M., Qian L.W., Sato N., Nagai E., Matsumoto K., Nakamura T., and Tanaka M. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64 (2004) 3215-3222
114. He X., Brenchley, PEC, Jayson G.C., Hampson L., Davies J., and Hampson IN. Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by anti-heparanase antibodies. Cancer Res 64 (2004) 3928-3933
115. Middleton J., Patterson A.M., Gardner L., Schmutz C., and Ashton BA. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100 (2002) 3853-3860
116. Gotte M. Syndecans in inflammation. FASEB J 17 (2003) 575-591
117. Hart M.N., Fabry Z., Love-Homan L., Keiner J., Sadewasser K.L., and Moore SA. Brain microvasculature, smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells. Am J Path 141 (1992) 421-427
118. Wang M.J., Kuo J.S., Lee W.W., Huang H.Y., Chen W.F., and Lin SZ. Translational event mediates differential production of tumor necrosis factor-alpha in hyaluronan-stimulated microglia and macrophages. J Neurochem 97 (2006) 857-871
119. Brown KA. Factors modifying the migration of lymphocytes across the blood-brain barrier. Int Immunopharmacol 1 (2001) 2043-2062
120. Giannelli G D., Marzo A., Scagnolari C., Bergamini C., Fransvea E., Bagnato F., Bellomi F., Millefiorini E., Gasperini C., Antonaci S., and Antonelli G. Proteolytic balance in patients with multiple sclerosis during interferon treatment. J Interferon Cytokine Res 22 (2002) 689-692
121. Siao C.J., and Tsirka SE. Extracellular proteases and neuronal cell death. Cell Mol Biol 48 (2002) 151-161
122. Kouwenhoven M., Ozenci V., Gomez A., Yarilin D., Giedraitis V., Press R., and Link H. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun 16 (2001) 463-470
123. Rosenberg G.A., Estrada E.Y., and Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion. Stroke 29 (1998) 2189-2195
124. Dubois B., Masure S., Hurtenbach U., Paemen L., Heremans H., van den Oord J., Sciot R., Meinhardt T., Hammerling G., Opdenakker G., and Arnold B. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 104 (1999) 1507-1514
125. Lepperd D., Ford J., Stabler G., Grygar C., Lienert C., Huber S., Miller K.M., Hauser S.L., and Kappos L. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121 (1998) 2327-2334
126. Yushchenko M., Mader M., Elitok E., Bitsch A., Dressel A., Tumani H., Bogumil T., Kitze B., Poser S., and Weber F. Interferon-beta-1 decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. J Neurol 250 (2003) 1224-1228
127. Gilli F., Bertolotto A., Sala A., Hoffmann F., Copobianco M., Malucchi S., Glass T., Kappos L., Lindberg R.L., and Lepperd D. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs. Brain 127 (2004) 259-268
128. Karabudak R., Kurane A., Guc D., Sengelen M., Canpinar H., and Kansu E. Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results. J Neurol 251 (2004) 279-283
129. Rosenberg G.A., Estrada E., Kelly R.O., and Kornfeld M. Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat. Neurosci Lett 160 (1993) 117-119
130. Leib S.L., Clements J.M., Lindberg R.L., Heimgartner C., Loeffler J.M., Pfister L.A., Tauber M.G., and Lepperd D. Inhibition of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124 (2001) 1734-1742
131. Kaul M., and Lipton SA. Mechanism of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4 (2006) 307-318
132. Satoh K., Hata M., Shimizu T., Yokota H., Akatsu H., Yamamoto T., Kosaka K., and Yamada T. Lib, transcriptionally induced in senile plaque-associated astrocytes, promotes glial migration through extracellular matrix. Biochem Biophys Res Commun 335 (2005) 631-636
133. Suryadevara R., Holter S., Borgmann K., Persidsky R L.-, Zink C., Persidsky Y., Gendelman H.E., Wu L., and Ghorpade. A. Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 44 (2003) 47-56
134. Giraudon P., Szymocha R., Buart S., Bernard A., Cartier L., Belin M.F., and Akaoka H. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-1 induced neurological disease. J Immunol 164 (2000) 2718-2727
135. Cladera J M.I.O., and Shea P. The fusion domain of HIV gp41 interacts specifically with heparin sulfate on the T-lymphocyte cell surface. EMBO J 20 (2001) 19-26
136. Tyagi M., Rusnati M., Presta M., and Giacca M. Internalization of HIV-1 Tat requires cell surface heparin sulfate proteoglycans. J Biol Chem 276 (2001) 3254-3261
137. Hallak L.K., Spillmann D., Collins P.L., and Peeples ME. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74 (2001) 10508-10513
138. Bolteus A.J., Berens M.E., and Pilkington GJ. Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 1 (2001) 225-232
139. Bellail A.C., Hunter S.B., Brat D.J., Tan C., and Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36 (2004) 1046-1069
140. Hibino S., Shibuya M., Engbring J.A., Mochizuki M., Nomizu M., and Kleinman HK. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 64 (2004) 4810-4816
141. Hibino S., Shibuya M., Hoffman M.P., Engbring J.A., Hossain R., Mochizuki M., Kudoh S., Nomizu M., and Kleinman HK. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparin sulfate chains of CD44. Cancer Res 65 (2005) 10494-10501
142. Ljubimova J.Y., Fugita M., Khazenzon N.M., Das A., Pikul B.B., Newman D., Sekiguchi K., Sorokin L.M., Sasaki T., and Black KL. Association between laminin-8 and glial tumor grade, recurrance, and patient survival. Cancer 101 (2004) 604-612
143. Zhou Z., Doi M., Wang J., Cao R., Liu B., Chan K.M., Kortesmaa J., Sorokin L., Cao Y., and Tryggvason K. Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice. Cancer Res 64 (2004) 4059-4063
144. Johansson F.K., Goransson H., and Westermark B. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 24 (2005) 3896-3905
145. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., and Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursor from human glioblastoma. Cancer Res 64 (2004) 7011-7021
146. Lin H.-X., Dahlin-Huppe K., and Stallcup WB. Interaction of the NG2 proteoglycan with the actin cytoskeleton. J Cell Biochem 63 (1996) 463-477
147. Mahesparan R., Read TA L.-, Johansen M., Skaftnesmo K.O., Bjerkvig R., and Engebraaten O. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 105 (2003) 49-57
148. Tatenhorst L., Senner V., Puttmann S., and Paulus W. Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 63 (2004) 210-222
149. Nuttall R.K., Pennington C.J., Taplin J., Wheal A., Yong V.W., Forsyth P.A., and Edwards DR. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res 1 (2003) 333-345
150. Esteve P.O., Chicone E., Robledo O., Aodjit F., Descoteaux A., Potworowski E.F., and St-Pierre Y. Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem 20 277 (2002) 35150-35155
151. Deryugina E.I., Soroceanu L., and Strongin AY. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62 (2002) 580-588
152. Wiranowska M., and Naidu AK. Interferon effect on glycasominoglycans in mouse glioma in vitro. J Neuro-Oncol 18 (1994) 9-17
153. Wiranowska M., Tresser N., and Saporta S. The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro. Anticancer Res 18 (1998) 3331-3338
154. Wiranowska M., Rojiani A.M., Gottschall P.E., Moscinski L.C., Johnson J., and Saporta S. CD44 expression and MMP-2 secretion by glioma cells: effect of interferon and anti-CD44 antibody. Anticancer Res 20 (2000) 4301-4306
155. Kasza A., Kowanetz M., Poslednik K., Witek B., Kordula T., and Koj A. Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells. Cytokine 16 (2001) 187-190
156. Brockmann M.A., Ulbricht U., Gruner K., Fillbrandt R., Westphal M., and Lamszus K. Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. J Neurosurg 52 (2003) 1391-1399